OBJECTIVE: The goal was to identify, among extremely low birth weight (<or=1000 g) live births, the proportion of infants who were unimpaired at 18 to 22 months of corrected age. METHODS: Unimpaired outcome was defined as Bayley Scales of Infant Development II scores of >or=85, normal neurologic examination findings, and normal vision, hearing, swallowing, and walking. Outcomes were determined for 5250 (86%) of 6090 extremely low birth weight inborn infants. RESULTS: Of the 5250 infants whose outcomes were known at 18 months, 850 (16%) were unimpaired, 1153 (22%) had mild impairments, 1147 (22%) had moderate/severe neurodevelopmental impairments, and 2100 (40%) had died. Unimpaired survival rates varied according to birth weight, from <1% for infants <or=500 g to 24% for infants 901 to 1000 g. The regression model to predict unimpaired survival versus death or impairment for live births (N = 5250) indicated that 25.3% of the variance was derived from infant factors present at birth, including female gender, higher birth weight, singleton birth. The regression model to predict unimpaired survival for discharged infants indicated that most of the variance was derived from combined effects of major neonatal morbidities, neonatal interventions, and maternal demographic features (15.7%) and only 8.5% was derived from infant factors present at birth. CONCLUSIONS: Although <1% of live-born infants of <or=500 g survive free of impairment at 18 months, this increases to almost 24% for infants of 901 to 1000 g. Female gender, singleton birth, higher birth weight, absence of neonatal morbidities, private health insurance, and white race increase the likelihood of unimpaired status.
OBJECTIVE: The goal was to identify, among extremely low birth weight (<or=1000 g) live births, the proportion of infants who were unimpaired at 18 to 22 months of corrected age. METHODS: Unimpaired outcome was defined as Bayley Scales of Infant Development II scores of >or=85, normal neurologic examination findings, and normal vision, hearing, swallowing, and walking. Outcomes were determined for 5250 (86%) of 6090 extremely low birth weightinborninfants. RESULTS: Of the 5250 infants whose outcomes were known at 18 months, 850 (16%) were unimpaired, 1153 (22%) had mild impairments, 1147 (22%) had moderate/severe neurodevelopmental impairments, and 2100 (40%) had died. Unimpaired survival rates varied according to birth weight, from <1% for infants <or=500 g to 24% for infants 901 to 1000 g. The regression model to predict unimpaired survival versus death or impairment for live births (N = 5250) indicated that 25.3% of the variance was derived from infant factors present at birth, including female gender, higher birth weight, singleton birth. The regression model to predict unimpaired survival for discharged infants indicated that most of the variance was derived from combined effects of major neonatal morbidities, neonatal interventions, and maternal demographic features (15.7%) and only 8.5% was derived from infant factors present at birth. CONCLUSIONS: Although <1% of live-born infants of <or=500 g survive free of impairment at 18 months, this increases to almost 24% for infants of 901 to 1000 g. Female gender, singleton birth, higher birth weight, absence of neonatal morbidities, private health insurance, and white race increase the likelihood of unimpaired status.
Authors: Betty R Vohr; Michael E Msall; Dee Wilson; Linda L Wright; Scott McDonald; W Kenneth Poole Journal: Pediatrics Date: 2005-07 Impact factor: 7.124
Authors: Susan R Hintz; Douglas E Kendrick; Betty R Vohr; W Kenneth Poole; Rosemary D Higgins Journal: Acta Paediatr Date: 2006-10 Impact factor: 2.299
Authors: Avroy A Fanaroff; Barbara J Stoll; Linda L Wright; Waldemar A Carlo; Richard A Ehrenkranz; Ann R Stark; Charles R Bauer; Edward F Donovan; Sheldon B Korones; Abbot R Laptook; James A Lemons; William Oh; Lu-Ann Papile; Seetha Shankaran; David K Stevenson; Jon E Tyson; W Kenneth Poole Journal: Am J Obstet Gynecol Date: 2007-02 Impact factor: 8.661
Authors: Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins Journal: Pediatrics Date: 2005-03 Impact factor: 7.124
Authors: Richard A Ehrenkranz; Anna M Dusick; Betty R Vohr; Linda L Wright; Lisa A Wrage; W Kenneth Poole Journal: Pediatrics Date: 2006-04 Impact factor: 7.124
Authors: Barbara J Stoll; Nellie I Hansen; Ira Adams-Chapman; Avroy A Fanaroff; Susan R Hintz; Betty Vohr; Rosemary D Higgins Journal: JAMA Date: 2004-11-17 Impact factor: 56.272
Authors: Myra H Wyckoff; Walid A Salhab; Roy J Heyne; Douglas E Kendrick; Barbara J Stoll; Abbot R Laptook Journal: J Pediatr Date: 2011-09-17 Impact factor: 4.406
Authors: Elizabeth Nance; Michael Porambo; Fan Zhang; Manoj K Mishra; Markus Buelow; Rachel Getzenberg; Michael Johnston; Rangaramanujam M Kannan; Ali Fatemi; Sujatha Kannan Journal: J Control Release Date: 2015-07-13 Impact factor: 9.776
Authors: P Kumar; S Shankaran; N Ambalavanan; D E Kendrick; A Pappas; B R Vohr; B B Poindexter; A Das; R D Higgins Journal: J Perinatol Date: 2013-06-27 Impact factor: 2.521
Authors: H Gerry Taylor; Nori Minich; Mark Schluchter; Kimberly Andrews Espy; Nancy Klein Journal: J Int Neuropsychol Soc Date: 2019-04 Impact factor: 2.892